Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXInability to comply with protocol-required proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients and physicians must be willing to comply with treatment assignment:Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients must be deemed able to comply with the treatment plan and follow-up scheduleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who are otherwise felt unable to comply with the protocol, in the opinion of the investigatorXx_NEWLINE_xXPatients who are able to comply with the protocol follow-up scheduleXx_NEWLINE_xXInability to comply with study and/or follow-up procedures.Xx_NEWLINE_xXInability to comply with study-related proceduresXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXAble to understand and comply with the study procedures, understand the risks involved in the study, and provide written informed consent before the first study-specific procedure; specifically able to comply with the PK assessment schedule during the first 2 treatment cycles.Xx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXInability to comply with visit schedule or other protocol requirements.Xx_NEWLINE_xXWilling to comply with clinical trial instructions and requirements, including mandatory biopsiesXx_NEWLINE_xXAbility to comply with the study protocol, in the investigator's judgmentXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXPatients must be deemed able to comply with the treatment plan and follow-up scheduleXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXAbility and willingness to comply with the study protocol for the duration of the study and with follow-up procedures.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXCOHORT 1: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXCOHORT 2: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXPatients who in the opinion of the investigator are unable to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatient must have the ability to comply with all study requirementsXx_NEWLINE_xXAbility to comply with study procedures in the Investigator's opinionXx_NEWLINE_xXSubjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXMust be able to comply with the treatment plan and follow-up scheduleXx_NEWLINE_xXWilling and able to comply with all aspects of the protocolXx_NEWLINE_xXPatients willing to comply with study requirementsXx_NEWLINE_xXMust be able to comply with the study and follow-up requirementsXx_NEWLINE_xXPatients must be willing and able to complete all study proceduresXx_NEWLINE_xXSubjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXIf premenopausal, patient must be willing to comply with pregnancy requirementsXx_NEWLINE_xXADJUVANT COHORT: If premenopausal, patient must be willing to comply with pregnancy requirementsXx_NEWLINE_xXPatient able and willing to comply with study procedures as per protocolXx_NEWLINE_xXPatient with history of poor compliance or history of drug/alcohol abuse, or excessive alcohol beverage consumption that would interfere with the ability to comply with the study protocol, or current or past psychiatric disease that might interfere with the ability to comply with the study protocol or give informed consentXx_NEWLINE_xXPatients unwilling to or unable to comply with the protocol or who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPsychiatric condition making the patient unlikely to comply with protocol therapy, required tests and follow-up.Xx_NEWLINE_xXInability to comply with study requirementsXx_NEWLINE_xXReliable and willing to make themselves available for the duration of the study and are willing to follow study-specific procedures.Xx_NEWLINE_xXAbility to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-upXx_NEWLINE_xXBe able to comply with the requirements of the entire study.Xx_NEWLINE_xXBe willing to comply with clinical trial instructions and requirements.Xx_NEWLINE_xXBe willing to comply with clinical trial instructions and requirements, including mandatory biopsies.Xx_NEWLINE_xXPatients >= 18 years must be willing to comply with the mandatory biopsies.Xx_NEWLINE_xXAbility to comply with the study protocol, in the investigator's judgmentXx_NEWLINE_xXWillingness and ability to comply with study and follow-up procedures.Xx_NEWLINE_xXParticipant must be willing and able to comply with all aspects of the protocolXx_NEWLINE_xXInability to comply with study and follow-up procedures.Xx_NEWLINE_xXPatient has signed the informed consent (ICF) prior to any screening procedures being performed and is able to comply with protocol requirementsXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatient has signed the informed consent prior to any screening procedures being performed and is able to comply with the protocol requirementsXx_NEWLINE_xXHistory of any psychiatric condition that might impair patient's ability to understand or comply with the requirements of the study or to provide consentXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient's ability to tolerate and/or comply with study requirements.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who, in the opinion of the investigator, are unable or unlikely to comply with the dosing schedule and study evaluationsXx_NEWLINE_xXWillingness and ability to comply with study and follow-up proceduresXx_NEWLINE_xXAbility to comply with the study protocol, in the investigator's judgmentXx_NEWLINE_xXJudgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirements.Xx_NEWLINE_xXHistory of any psychiatric condition that might impair patient's ability to understand or comply with the requirements of the study or to provide consentXx_NEWLINE_xXWilling and able to participate in the trial and comply with all trial requirements.Xx_NEWLINE_xXSubject is able to understand and willing to comply with protocol requirements and instructionsXx_NEWLINE_xXSubject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required procedures.Xx_NEWLINE_xXPatients must be able to comply with all protocol requirementsXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXJudgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and/or requirements.Xx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXLimitation of the patient's ability to comply with the treatment or follow-up protocol.Xx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXSubjects likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledgeXx_NEWLINE_xXWilling and able to comply with study requirements for follow-upXx_NEWLINE_xXPatients who cannot comply with protocol requirements including clinic visits for intravenous infusions and birth control measures may not be enrolled.Xx_NEWLINE_xXPatients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAre willing and able to comply with the protocol requirementsXx_NEWLINE_xXWillingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAbility to comply with dietary and tobacco/alcohol abstinence requirements.Xx_NEWLINE_xXSubject is able to comply with study procedures and follow-up examinationsXx_NEWLINE_xXSubject is able to understand and comply with protocol requirements and instructionsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXSubjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXUnwillingness to follow study protocol and compliance proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXSubjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.Xx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXPatient must be able and willing to comply with study procedures as per protocolXx_NEWLINE_xXInability to comply with study proceduresXx_NEWLINE_xXSubjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and proceduresXx_NEWLINE_xXWillingness and capability to comply with the requirements of the study.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXWillingness and ability to comply with study procedures and follow-up examinationXx_NEWLINE_xXAble to comply with the study protocol, in the investigator’s judgmentXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.Xx_NEWLINE_xXWillingness to give consent and comply with all study-related evaluations and treatment schedule; andXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXWillingness and ability of the subject to comply with study activities.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXJudgment by the Investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirements.Xx_NEWLINE_xXBe willing to comply with treatment protocolXx_NEWLINE_xXInability to comply with protocol required proceduresXx_NEWLINE_xXAbility to comply with the treatment scheduleXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirementXx_NEWLINE_xXPatient must be willing to comply with all aspects of the protocol including completing the drug diaryXx_NEWLINE_xXSTUDY ENTRY: Ability and willingness to comply with the requirements of the study protocol.Xx_NEWLINE_xXGENERAL: Inability to comply with study and follow-up procedures.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAbility to comply with the study protocol, in the investigator's judgmentXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXWillingness and ability to comply with the trial and follow-up procedures.Xx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXAble to swallow the study drug and comply with study requirementsXx_NEWLINE_xXAbility to comply with all study procedures and willingness to remain supine for 120 minutes during imagingXx_NEWLINE_xXInability to comply with study and follow-up procedures.Xx_NEWLINE_xXPatient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXSubjects deemed unable to comply with study and/or follow-up procedures.Xx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXStated willingness to comply with study procedures and duration.Xx_NEWLINE_xXInability to comply with study procedures or willingness to use adequate birth controlXx_NEWLINE_xXInability to comply with study and follow up proceduresXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, willingness and ability of the subject to understand and comply with study proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, are unable or unlikely to comply with the dosing schedule and study evaluationsXx_NEWLINE_xXParticipants must be willing to comply with all aspects of the protocol.Xx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXAble to comply with study protocol, in the investigator’s judgmentXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXUnderstand the study requirements and the treatment procedures, and is willing to comply with all specified follow-up evaluations, and provides written informed consent before any study-specific tests or procedures are performed.Xx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXPatients willing to comply with the clinical trial protocolXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXWilling and able to give informed consent and comply with all aspects of the protocolXx_NEWLINE_xXStated willingness to comply with all study procedures and be available for the duration of the trialXx_NEWLINE_xXAbility and capacity to comply with the study and follow-up proceduresXx_NEWLINE_xXAble to swallow the study drug, have no known intolerance to study drugs or excipients, and comply with study requirements.Xx_NEWLINE_xXSubject is able to understand and willing to comply with protocol requirements and instructionsXx_NEWLINE_xXAbility to comply with protocol requirements.Xx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXPatient, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXAbility to comply with the protocol.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAble to swallow sunitinib and comply with study requirementsXx_NEWLINE_xXMust be males or non-pregnant females who agree to comply with applicable contraceptive requirements of the protocol.Xx_NEWLINE_xXMust understand and be able, willing, and likely to fully comply with study procedures and restrictions.Xx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.Xx_NEWLINE_xXWilling and able to complete study procedures within the study timelinesXx_NEWLINE_xXWillingness and ability of subject to comply to study requirementsXx_NEWLINE_xXBe willing to comply with treatment protocolXx_NEWLINE_xXInability to comply with the study and follow-up procedures.Xx_NEWLINE_xXSubjects with active alcohol or drug addiction that would interfere with their ability to comply with the study requirementsXx_NEWLINE_xXPatients who cannot comply with the study requirementsXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXBe willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.Xx_NEWLINE_xXPatients unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXCELL PROCUREMENT: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study proceduresXx_NEWLINE_xXLYMPHODEPLETION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study proceduresXx_NEWLINE_xXiC9-CAR19 CELL INFUSION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study proceduresXx_NEWLINE_xXPatients must sign informed consent form (ICF) and show ability and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXIn the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator may not be able to comply with IL-2 or ECP treatment requirements or the safety monitoring requirements of the study, will be excluded from participationXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions, and requirementsXx_NEWLINE_xXBe willing to participate in the study and comply with all study requirementsXx_NEWLINE_xXAble to swallow study drug and comply with study requirementsXx_NEWLINE_xXAble to swallow study drug and comply with study requirementsXx_NEWLINE_xXReliable and willing to make themselves available for the duration of the study and are willing to follow study proceduresXx_NEWLINE_xXAble to comply with the treatment scheduleXx_NEWLINE_xXNon-compliance; defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatient has demonstrated compliance with the parent study requirements, as assessed by the principal investigator and patient is able to comply with the necessary visits and assessments as part of the rollover studyXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatient that is not able to understand or to comply with the study instructions and requirements, or has a history of non-compliance to the medical regimenXx_NEWLINE_xXInability to comply with protocol or study proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are NOT eligible for either StratumXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient’s ability to tolerate and/or comply with study requirementsXx_NEWLINE_xXParticipants must be able to understand and willing to comply with protocol requirements as assessed by the investigator.Xx_NEWLINE_xXAble to understand and comply with protocol requirements for the entire length of the studyXx_NEWLINE_xXCapable of understanding the protocol requirements, is willing and able to comply with the study protocol procedures, and has signed the informed consent document.Xx_NEWLINE_xXSubject is, in the investigator’s opinion, willing and able to comply with the protocol requirementsXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXFor the patient or parent/legal guardian to be able to comply with treatment plan, study procedures and follow-up examinationsXx_NEWLINE_xXPatients who are not available for follow-up assessments or unable to comply with study requirementsXx_NEWLINE_xXDONOR: Able and willing to comply with the requirements of the protocolXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXWillingness and ability to comply with all study procedures and able to take oral medicationsXx_NEWLINE_xXPatients must be willing and able to undergo biopsy according to the institute’s own guidelines and requirements for such proceduresXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXAbility to comply with the treatment scheduleXx_NEWLINE_xXWillingness and ability to comply with study procedures and follow-up examinationsXx_NEWLINE_xXInability to comply with protocol required proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAbility to understand and comply with study procedures for the entire length of the study as determined by the site investigator or protocol designeeXx_NEWLINE_xXAble to swallow study drug and comply with study requirementsXx_NEWLINE_xXInability to comply with the safety monitoring requirements of the study, as judged by the investigatorXx_NEWLINE_xXAbility to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-upXx_NEWLINE_xXBe willing and able to comply with this protocolXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXNONCOMPLIANCE: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXSubject is able and willing to comply with the requirements of the protocol.Xx_NEWLINE_xXUnable to comply with study requirements in the opinion of the Investigator.Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXWilling and able to comply with all study requirements, including treatment, and attending required assessmentsXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXWilling and able to comply with all study proceduresXx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXSubjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXMust be willing and able to comply with studyXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.Xx_NEWLINE_xXInability to comply with study procedures.Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAble to swallow the study drug and comply with study requirementsXx_NEWLINE_xXAbility to comply with study and follow-up proceduresXx_NEWLINE_xXThe subject is able to understand and comply with protocol requirements, timetables, instructions and protocol-stated restrictionsXx_NEWLINE_xXAbility to comply with requirements of the protocol, as assessed by the investigator by the patient signing the consent formXx_NEWLINE_xXParticipant must be willing to comply with study and/or follow-up proceduresXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient's ability to comply with study requirementsXx_NEWLINE_xXResearch participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXParticipant must be willing and comply with the requirements of the protocolXx_NEWLINE_xXInability to comply with protocol or study proceduresXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAble to comply with the treatment scheduleXx_NEWLINE_xXPatient is willing and able to comply with protocol required assessments and proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXBe able to comply with study procedures and follow-up examinationsXx_NEWLINE_xXAble to comply with the protocol, including tissue sampling, imaging studies and surgical interventionXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with all the study requirementsXx_NEWLINE_xXCOHORTS 1 AND 2: HEALTHY VOLUNTEERS: Subjects must participate fully and be willing to comply with the procedures of the protocolXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatients willing and able to comply with the study protocol for the duration of the studyXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXAbility to swallow study drugs and to comply with study requirements throughout the studyXx_NEWLINE_xXBe able to comply with the requirements of the entire study.Xx_NEWLINE_xXWilling to comply with study proceduresXx_NEWLINE_xXAble and willing to comply with testing and treatment as outlined in this protocolXx_NEWLINE_xXInability or unwillingness to comply with radiation safety procedures or protocol requirementsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXWillingness to comply with study guidelinesXx_NEWLINE_xXPatients must demonstrate the ability and willingness to follow the study requirements.Xx_NEWLINE_xXInability or unwillingness to comply with radiation safety procedures or protocol requirementsXx_NEWLINE_xXPatient is unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator that the patient is not suitable for participation in the study.Xx_NEWLINE_xXMust be available during the duration of the study and willing to follow the study proceduresXx_NEWLINE_xXPatient is currently enrolled in a Novartis-sponsored, Oncology Clinical Development & Medical Affairs study receiving imatinib and has fulfilled all their requirements in the parent study. 2.Patient is currently benefiting from the treatment with imatinib, as determined by the investigator. 3. Patient has demonstrated compliance, as assessed by the investigator, with the parent study protocol requirements.4. Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures. 5. Written informed consent obtained prior to enrolling in roll-over study.Xx_NEWLINE_xXPatients who cannot comply with medicationsXx_NEWLINE_xXPatients must be willing and able to give written informed consent prior to any protocol-specific procedures being performed and comply with the protocol requirements for the duration of the study.Xx_NEWLINE_xXPatient able and willing to comply with study procedures as per protocolXx_NEWLINE_xXAbility to comply with the protocol procedures (including geographic accessibility)Xx_NEWLINE_xXPatients must be able to comply with the protocol treatments and procedures.Xx_NEWLINE_xXHave the ability to understand and comply with the requirements and follow-up time points of the studyXx_NEWLINE_xX223 Subjects likely to not be available to complete all protocol- required study visits or procedures including BM aspirates/biopsies, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.Xx_NEWLINE_xXWillingness and ability to comply with study and follow-up proceduresXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXSubject is willing and able to comply with the protocol for the duration of the studyXx_NEWLINE_xXWilling and able to comply with all study requirements, including treatment, timing and nature of required assessmentsXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXWillingness and ability to comply with study and follow-up procedures.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocol.Xx_NEWLINE_xXInability to comply with study and follow-up procedures.Xx_NEWLINE_xXInability to comply with the study and follow-up procedures.Xx_NEWLINE_xXPatients must agree/be able to comply with all protocol specific requirementsXx_NEWLINE_xXInability to comply with the study and follow-up proceduresXx_NEWLINE_xXSubjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXJudgment by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXAble to comply with the study protocol, in the investigator’s judgmentXx_NEWLINE_xXSubjects is willing and able to comply with study procedures based on the judgement of the investigator or protocol designeeXx_NEWLINE_xXAre able and willing to comply with all study procedures.Xx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXAble to comply with the protocol, including tissue and blood samplingXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXHave the willingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.Xx_NEWLINE_xXThe subject must be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.Xx_NEWLINE_xXInability to comply with study and follow-up procedures as judged by the investigatorXx_NEWLINE_xXState willingness to comply with all study procedures and be available for the duration of the trialXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.Xx_NEWLINE_xXPatient must be able and willing to comply with study procedures as per protocolXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAny condition or behavior that in the judgment of the investigator, would compromise the patient’s ability to participate in the study and/or comply with study proceduresXx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient's ability to tolerate and/or comply with study requirements.Xx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatients should be able to swallow enzalutamide and comply with study requirementsXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXNon-compliance: subjects who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study will be considered non-compliantXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXNon-compliance: if it is the opinion of the investigator that a subject may be unable to comply with the safety monitoring requirements of the study, they will be excludedXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXMedically and psychologically able to comply with all study requirementsXx_NEWLINE_xXEmotional limitations, which the investigator judges could limit the patient's ability to follow up and comply with study proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatients who, for medical or other reasons, are unable to comply with the study proceduresXx_NEWLINE_xXMedically and psychologically able to comply with all study requirementsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAbility to give written informed consent and willingness to comply with the requirements of the protocolXx_NEWLINE_xXAble and willing to comply with study criteriaXx_NEWLINE_xXAbility and willingness to comply with all study requirementsXx_NEWLINE_xXWilling and able to comply with all study proceduresXx_NEWLINE_xXInability to comply with the protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXWilling and able to comply with study proceduresXx_NEWLINE_xXVasectomy or surgical castration ? 6 months prior to Screening. 13. Subjects able to swallow study medication 14. Subjects able to comply with study requirementsXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXWilling and able to comply with follow-up scheduleXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with other requirements of the protocolXx_NEWLINE_xXLimitation of the patient's ability to comply with the treatment or to follow-up the protocol.Xx_NEWLINE_xXAny condition that in the opinion of the investigator would impair the patients' ability to comply with the study procedures.Xx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXSubjects who, in the opinion of the investigator, are unable or unlikely to comply with the dosing schedule and study evaluationsXx_NEWLINE_xXSubject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject's and investigator's knowledge.Xx_NEWLINE_xXHave the willingness and ability to comply with scheduled visit and study procedures.Xx_NEWLINE_xXSubjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.Xx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient's ability to tolerate and/or comply with study requirements.Xx_NEWLINE_xXPatients must comply with the treatment plan and follow-up schedule.Xx_NEWLINE_xXAbility to comply with the study protocol, in the investigator’s judgmentXx_NEWLINE_xXLimitation of the patient's ability to comply with the treatment or follow-up requirements.Xx_NEWLINE_xXParticipant must be willing and able to comply with all aspects of the protocol.Xx_NEWLINE_xXWilling to comply with study proceduresXx_NEWLINE_xXBe willing and able to comply with all aspects of the protocolXx_NEWLINE_xXWilling and able to comply with all aspects of the protocolXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements and/or follow-up studies of this trialXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXBe willing to comply with effective antiretroviral therapy (ARV)Xx_NEWLINE_xXWilling and able to comply with all aspects of the treatment protocolXx_NEWLINE_xXAbility to comply with endometrial biopsies every 3 monthsXx_NEWLINE_xXSubjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and proceduresXx_NEWLINE_xXPatient has signed the informed consent (ICF) prior to any screening procedures being performed and is able to comply with protocol requirements.Xx_NEWLINE_xXPatients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, the subject should be able to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXAbility to comply with study proceduresXx_NEWLINE_xXHistory of noncompliance to medical regimens or unwillingness to comply with the protocolXx_NEWLINE_xXAbility to understand the nature of this study protocol, comply with study and/or follow-up procedures, and give written informed consentXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXSubject must be able to swallow study drug and comply with study requirements.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXWilling and able to comply with all study requirements, including treatment and required assessmentsXx_NEWLINE_xXJudgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXPatient must be able to give informed consent and comply with the treatment protocol and follow-up plan.Xx_NEWLINE_xXPatients must meet the following criteria on screening examination to be eligible to participate in the study; all laboratory assessments should be performed within 21 days of initiation of protocol therapy unless otherwise specified; subject is, in the investigator’s opinion, willing and able to comply with the protocol requirementsXx_NEWLINE_xXPatient is willing and able to participate in the study and comply with all study requirements.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXInability to comply with the study and follow-up proceduresXx_NEWLINE_xXWillingness to comply with all study interventions and follow-up proceduresXx_NEWLINE_xXAs judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirementsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with the protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXThe patient is able and willing to comply with all study related proceduresXx_NEWLINE_xXWillingness and ability to comply with study and follow-up procedures.Xx_NEWLINE_xXSubjects unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects deemed unable to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatient must be willing to comply with study proceduresXx_NEWLINE_xXResearch participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXIs unable to comply with study requirementsXx_NEWLINE_xXIndividuals not willing to comply with the procedural requirements of this protocolXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXSubject is able to swallow the study drug and comply with study requirements.Xx_NEWLINE_xXThe patient or parent(s)/guardian(s) is/are unable to comply with the study visit schedule and other protocol requirements, in the opinion of the investigator.Xx_NEWLINE_xXInability to comply with protocol required procedures.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up procedures (i.e. unwilling to undergo protocol-mandated biopsies if feasible)Xx_NEWLINE_xXIs able and willing to follow all study proceduresXx_NEWLINE_xXIndividuals not willing to comply with the procedural requirements of this protocolXx_NEWLINE_xXAble to swallow the study drug and comply with study requirementsXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXInability to comply with the protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXPatients must be willing and able to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXWilling and able to comply with all aspects of the protocolXx_NEWLINE_xXInability to comply with the protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXInability to comply with the protocol and/or not willing or not available for follow-up assessments.Xx_NEWLINE_xXInability to comply with protocol or study proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, are unable to comply with the requirements of the study protocol are not eligibleXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXCancer of the Liver Italian Program (CLIP) score > 3; inability to comply with study and/or follow-up proceduresXx_NEWLINE_xXBe able to comply with treatment plan, study procedures and follow-up examinationsXx_NEWLINE_xXPatients who are not available for follow-up assessments or unable to comply with study requirementsXx_NEWLINE_xXPatient unable to comply with the protocol, in the opinion of the investigator.Xx_NEWLINE_xXAble to swallow the study drug and comply with study requirementsXx_NEWLINE_xXable to comply with all study-related procedures, medication use, and evaluations.Xx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXAbility to give written informed consent and willingness to comply with the requirements of the protocolXx_NEWLINE_xXAble to comply with scheduled follow-up and with management of toxicityXx_NEWLINE_xXPatients who, for any reason, are not able to comply with the national legislationXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXAbility to give written informed consent and willingness to comply with the requirements of the protocolXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXAble to comply with scheduled follow-up and with management of toxicity.Xx_NEWLINE_xXPatients who, for any reason, are not able to comply with the national legislation.Xx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXMust be able to comply with study and follow up requirementsXx_NEWLINE_xXPsychiatric illness or social situation that would limit the patient's ability to comply with study requirementsXx_NEWLINE_xXInability to comply with study requirementsXx_NEWLINE_xXPatients must be willing to comply with effective Antiretroviral Therapy.Xx_NEWLINE_xXAre reliable and willing to make themselves available for the duration of the study and are willing to follow study proceduresXx_NEWLINE_xXInability to comply with the study and/or follow-up procedures.Xx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXAre reliable and willing to make themselves available for the duration of the study and are willing to follow study proceduresXx_NEWLINE_xXAbility to comply with study procedures, in the Investigator's opinionXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXSubject must be willing and able to comply with all aspects of the protocolXx_NEWLINE_xXWilling and able to understand the nature of this study and to comply with the study and follow-up procedures.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXPatients who are not able to comply with study and/or follow up proceduresXx_NEWLINE_xXInability to comply with protocol required proceduresXx_NEWLINE_xXStated willingness of patient to comply with study procedures and reporting requirements.Xx_NEWLINE_xXInability to comply with study and/or follow-up procedures.Xx_NEWLINE_xXAbility to comply with endometrial biopsies every 3 monthsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXBe willing to comply with the protocol.Xx_NEWLINE_xXSufficient mental capacity to comply with the protocol requirements,Xx_NEWLINE_xXWilling and able to participate in the trial and comply with all trial requirements.Xx_NEWLINE_xXWilling to comply with study procedures and follow-upXx_NEWLINE_xXParticipant is willing and able to comply with the requirements of the protocolXx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXAble to swallow the study drug as prescribed and comply with study requirementsXx_NEWLINE_xXWilling and able to participate in the trial and comply with all trial requirementsXx_NEWLINE_xXParticipant is willing and able to comply with the requirements of the protocolXx_NEWLINE_xXParticipant must be willing to comply with study and/or follow-up proceduresXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXPatients, who in the opinion of the investigator, are unlikely to comply with follow-up visits or other study requirements; patients who are currently part of or have participated in any clinical investigation with an investigational drug within 1 month prior to dosingXx_NEWLINE_xXSubject is willing and able to comply with the requirements of the protocol.Xx_NEWLINE_xXAbility to swallow study drugs and to comply with study requirements throughout the study.Xx_NEWLINE_xXInability to comply with study or follow-up testing and proceduresXx_NEWLINE_xXSubject is unlikely to comply with the protocol requirements, instructions and study-related restrictionsXx_NEWLINE_xXSubject's inability to comply with study and follow-up procedures, as judged by the Investigator.Xx_NEWLINE_xXPatients must be willing to comply with study proceduresXx_NEWLINE_xXAble to comply with the treatment scheduleXx_NEWLINE_xXBe able to comply with study procedures and follow-up examinationsXx_NEWLINE_xXSubject is able to understand and comply with protocol requirements and instructionsXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXWillingness and ability to comply with study and followup procedures.Xx_NEWLINE_xXWillingness and ability to comply with study and follow-up proceduresXx_NEWLINE_xXAbility to comply with an oral drug regimenXx_NEWLINE_xXInability to comply with protocol or study proceduresXx_NEWLINE_xXWilling and able to participate in the trial and comply with all trial requirements.Xx_NEWLINE_xXUnable to comply with the study follow-up scheduleXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXInability to comply with protocol-specified procedures (i.e., treatment, monitoring, or follow-up)Xx_NEWLINE_xXAs judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirementsXx_NEWLINE_xXBe willing and able to comply with the protocolXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXWilling and able to comply with all aspects of the treatment protocol.Xx_NEWLINE_xXAbility and willingness to comply with the requirements of the study protocolXx_NEWLINE_xXThe patient must be willing and able to comply with study requirements, remain at the clinic, and be willing and able to return to the clinic for the follow-up evaluation as specified in this protocol during the study period.Xx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXAble to swallow the study drug, have no known intolerance to the study drug or excipients, and comply with study requirements.Xx_NEWLINE_xXA subject who, in the opinion of the sponsor-investigator will be uncooperative or unable to comply with study proceduresXx_NEWLINE_xXAbility and willingness to comply with study visits, treatment, testing, and to comply with the protocol, in the investigator's judgmentXx_NEWLINE_xXInability to comply with study and follow-up proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXPatient must be willing and able to comply with the study procedures and visit schedules and must be able to follow verbal and written instructions.Xx_NEWLINE_xXFailure to enroll and comply with Alliance A031201Xx_NEWLINE_xXWilling to give consent and comply with study-related evaluation and treatment schedule; andXx_NEWLINE_xXPatient able and willing to comply with study procedures as per protocol, including the geriatric assessment at the time of study enrollmentXx_NEWLINE_xXAbility to comply with the protocolXx_NEWLINE_xXSubject must be willing to comply with all procedures and assessments.Xx_NEWLINE_xXDrug abuse, alcohol abuse, or other factors that in the opinion of the investigator could affect the ability of the subject to comply with the requirements of the protocol.Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXAble and willing to comply with all study procedures.Xx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAble and willing to comply with protocol requirements, in the opinion of the investigator.Xx_NEWLINE_xXMust be able and willing to comply with the study visit schedule and study procedures.Xx_NEWLINE_xXMust be able to understand and comply with protocol requirements and instructionsXx_NEWLINE_xXInability to comply with requirements of the protocolXx_NEWLINE_xXPatients with the inability or with foreseeable incapacity, in the opinion of the Investigator, to comply with the protocol requirements.Xx_NEWLINE_xXSubject is able and willing to comply with the requirements of the protocol.Xx_NEWLINE_xXUnable to comply with study requirements in the opinion of the Investigator.Xx_NEWLINE_xXParticipant is willing and able to comply with the requirements of the protocolXx_NEWLINE_xXPatients with the inability, in the opinion of the Investigator, to comply with the protocol requirementsXx_NEWLINE_xXAre reliable and willing to make themselves available for the duration of the study and are willing to follow study proceduresXx_NEWLINE_xXInability to comply with study or follow-up testing and proceduresXx_NEWLINE_xXInability to comply with study and/or follow up proceduresXx_NEWLINE_xXInability to comply with protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXInability to comply with study-related proceduresXx_NEWLINE_xXPatient is unable to comply with the requirements of the study.Xx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXReliable and available for the duration of the study and willing to follow study procedures.Xx_NEWLINE_xXIn the view of the investigator, the patient can and will comply with the requirements of the protocol.Xx_NEWLINE_xXAble to understand and comply with the requirements of the protocolXx_NEWLINE_xXWilling to comply with study procedures and follow-upXx_NEWLINE_xXParticipants who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXIn the view of the investigator, the patient can and will comply with the requirements of the protocol.Xx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXWilling and able to comply with the protocol guidelines for the duration of the studyXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligibleXx_NEWLINE_xXWillingness and ability to comply with all study proceduresXx_NEWLINE_xXInability to comply with the study proceduresXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xX201 Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.Xx_NEWLINE_xXInability of the subject to comply with study procedures and/or follow-upXx_NEWLINE_xXPatients who are not able to comply with study and/or followup proceduresXx_NEWLINE_xXAble to swallow enzalutamide and comply with study requirementsXx_NEWLINE_xXSubjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.Xx_NEWLINE_xXAbility and capacity to comply with study and follow-up proceduresXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAble to give informed consent, and comply with study proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXAbility to understand study procedures and to comply with them for the entire length of the studyXx_NEWLINE_xXWilling and able to comply with all aspects of study proceduresXx_NEWLINE_xXAble and willing to comply with all study related proceduresXx_NEWLINE_xXWilling to comply with study procedures and reporting requirementsXx_NEWLINE_xXNot willing to comply with study procedures and reporting requirementsXx_NEWLINE_xXSubject is willing and able to comply with the follow-up regimenXx_NEWLINE_xXWilling to comply with all study procedures and be available for the duration of the study.Xx_NEWLINE_xXParticipant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCTXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXParticipant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCTXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXPatients who are able to comply with the anti-emetic therapyXx_NEWLINE_xXWilling to comply with study procedures and reporting requirementsXx_NEWLINE_xXNot willing to comply with study procedures and reporting requirementsXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXParticipant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCTXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with study proceduresXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXBe able to understand study procedures and comply with them for the entire length of the study periodXx_NEWLINE_xXAbility to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXSubjects with active alcohol or drug addiction that would interfere with their ability to comply with the study requirementsXx_NEWLINE_xXAbility to comply with study procedures for the entire length of the studyXx_NEWLINE_xXAble and willing to give informed assent and comply with study requirementsXx_NEWLINE_xXWilling and able to comply with the requirements of the protocolXx_NEWLINE_xXAbility to understand and comply with the requirements of this studyXx_NEWLINE_xXPatient that is not able to understand or to comply with the study instructions and requirements or has a history of non-compliance to the medical regimenXx_NEWLINE_xXPatients must be deemed able to comply with the treatment plan and follow-up scheduleXx_NEWLINE_xXAny patients who are unable to comply with the study procedures as determined by the study investigatorsXx_NEWLINE_xXAbility to understand and comply with study guidelinesXx_NEWLINE_xXInvestigator has concerns regarding the ability of the subject to give written informed consent and/or to comply with study procedures (including availability for follow up visits).Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatient is able to understand and comply with protocol requirements and instructionsXx_NEWLINE_xXAny patient, in the opinion of the investigator, who is unable or unlikely to comply fully with the study requirements or procedures for any reasonXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubject is willing and able to comply with all aspects of the treatment and evaluation schedule.Xx_NEWLINE_xXThe subject is willing and able to comply with the study protocolXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAbility to understand study procedures and to comply with them for the entire length of the studyXx_NEWLINE_xXThe subject is willing to comply with 30-day follow-up in the office and answer quality-of-life questionnaires per protocolXx_NEWLINE_xXThe subject is willing to comply with 90-day follow-up by phoneXx_NEWLINE_xXThe subject is not willing to comply with 60-day follow-up in the office and answer quality-of-life questionnaires per protocolXx_NEWLINE_xXThe subject is not willing to comply with 90-day follow-up by phoneXx_NEWLINE_xXInability to comply with study and/or follow-up proceduresXx_NEWLINE_xXUnwillingness to comply with the requirements of the protocolXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXNon-compliance defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubject agrees to comply with the study requirements and agrees to come to the clinic for required study visitsXx_NEWLINE_xXWilling to follow protocol requirementsXx_NEWLINE_xXWillingness to comply with all study interventions of acupuncture and follow-up assessmentsXx_NEWLINE_xXAble to co-operate with the investigator and to comply with the requirements of the entire study.Xx_NEWLINE_xXParticipant is willing to be randomized and able to comply with the protocolXx_NEWLINE_xXPatient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.Xx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXWilling and able to comply with trial protocol and follow-upXx_NEWLINE_xXWillingness to comply with study guidelinesXx_NEWLINE_xXWilling and able to comply with trial protocol and follow-upXx_NEWLINE_xXWillingness to comply with all study interventions and follow-up proceduresXx_NEWLINE_xXWilling and able to comply with trial protocol and follow-upXx_NEWLINE_xXRECIPIENT: Participant must be willing to comply with study and/or follow?up procedures, including willingness to be followed for one year post?HCTXx_NEWLINE_xXRECIPIENT: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXSubject capable of providing written informed consent prior to initiation of any study procedures; subjects able to understand and comply with planned study procedures and be available for all study visitsXx_NEWLINE_xXWillingness to comply with all study interventions and follow-up procedures including the ability to apply the study drug to the breastXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXWilling and able to comply with trial protocol and follow-upXx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXWillingness to comply with all treatment and follow up proceduresXx_NEWLINE_xXSubjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXA subject who, in the opinion of the sponsor-investigator will be uncooperative or unable to comply with study proceduresXx_NEWLINE_xXPatients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.Xx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXAbility to comprehend and comply with the requirements of the StudyXx_NEWLINE_xXWillingness to comply with all study interventions and follow-up procedures including the ability to swallow the study drugXx_NEWLINE_xXWillingness to comply with study guidelinesXx_NEWLINE_xXSubjects who the investigator believes can and will comply with the requirements of the protocol.Xx_NEWLINE_xXHas any condition that interferes with the ability of the subject to understand or comply with the requirements of the study.Xx_NEWLINE_xXSubjects who the investigator believes can and will comply with the requirements of the protocolXx_NEWLINE_xXInability to comply with protocol and/or not willing or not available for follow-up assessmentsXx_NEWLINE_xXPatients who are not able to comply with study and/or follow-up proceduresXx_NEWLINE_xXStated willingness to comply with all required (non-optional) study procedures and be available for the duration of the studyXx_NEWLINE_xXProspective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)Xx_NEWLINE_xXBe conscious and able to comply with study proceduresXx_NEWLINE_xXSubject must be willing to comply with all clinical study proceduresXx_NEWLINE_xXWillingness to comply with the study protocolXx_NEWLINE_xXWilling to comply with all study procedures and be available for the duration of the studyXx_NEWLINE_xXInability to comply with study proceduresXx_NEWLINE_xXWilling to comply with protocol requirementsXx_NEWLINE_xXPATIENT: Be able to comply with study proceduresXx_NEWLINE_xXSubject deemed unlikely to be able to comply with instructions during imagingXx_NEWLINE_xXInability to comply with protocol requirementsXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAbility and willingness to comply with the study proceduresXx_NEWLINE_xXPatient is willing to comply with protocol requirementsXx_NEWLINE_xXMust be able to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXWilling to comply with all study procedures and be available for the duration of the study.Xx_NEWLINE_xXNot willing to comply with the procedural requirements of this protocolXx_NEWLINE_xXSubjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXPatient is not likely to comply with the follow-up evaluation scheduleXx_NEWLINE_xXWomen willing to comply with protocol requirementsXx_NEWLINE_xXPatients willing to comply with protocol requirementsXx_NEWLINE_xXJudgment by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions and requirementsXx_NEWLINE_xXPatients must be able to comply with the safety monitoring of the study in the opinion of the investigatorXx_NEWLINE_xXPatients who are unable to comply with study and/or follow up proceduresXx_NEWLINE_xXThe patient is willing and able to comply with the study protocolXx_NEWLINE_xXAbility to give informed consent and to comply with study proceduresXx_NEWLINE_xXEligible subjects must be able and willing to undergo the procedures of the studyXx_NEWLINE_xXProvides written informed consent and willing to comply with protocol requirementsXx_NEWLINE_xXWilling and able to undergo all study proceduresXx_NEWLINE_xXForeseen inability to comply with study requirementsXx_NEWLINE_xXAs judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirementsXx_NEWLINE_xXWilling and able to comply with all aspects of the protocol.Xx_NEWLINE_xXCapable and willing to comply with the entire study protocolXx_NEWLINE_xXPatients not able to comply with the study proceduresXx_NEWLINE_xXWillingness to comply with the requirements of the studyXx_NEWLINE_xXAs judged by the investigator, the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirementsXx_NEWLINE_xXAre willing and able to comply with study procedures and instructions, including completion of diaries.Xx_NEWLINE_xXWilling and able to comply with all study proceduresXx_NEWLINE_xXPatient is not likely to comply with the follow-up evaluation scheduleXx_NEWLINE_xXAble and willing to follow study procedures and instructions.Xx_NEWLINE_xXLimitation of the patient's ability to comply with the treatment or follow-up protocol.Xx_NEWLINE_xXRequired observations: Subjects who in opinion of investigator may not be able to comply with required safety and monitoring requirements are not eligibleXx_NEWLINE_xXAble and willing to follow study procedures and instructions.Xx_NEWLINE_xXAvailable for all study visits and able to comply with all study requirements.Xx_NEWLINE_xXPatients who are able to comply with the protocol.Xx_NEWLINE_xXSubjects must be able and willing to follow study procedures and instructions.Xx_NEWLINE_xXWillingness and ability to comply with the trial and follow-up procedures.Xx_NEWLINE_xXSubject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.Xx_NEWLINE_xXParticipants must be willing and able to comply with all aspects of the protocol.Xx_NEWLINE_xXNote: Abstinence is acceptable if this is the usual lifestyle and preferred contraception for the subject; as determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xXWillingness and ability to comply with study proceduresXx_NEWLINE_xXPatients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the studyXx_NEWLINE_xXAs determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the studyXx_NEWLINE_xX